Floatz logo

Amitriptyline

Anxiety Disorders

Hannover Medical SchoolSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Anxiety Disorders cohort.

Asset / SponsorPhaseRating
Sertraline
Holland Bloorview Kids Rehabilitation Hospital
Phase 4BBB
Risperdal
Tianjin Medical University General Hospital
Phase 4BBB
Olanzapine
Tianjin Medical University General Hospital
Phase 4BBB
FLUOXETINE
Hannover Medical School
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Theresa Jacob, PhD, MPH
Phase 4BBB

View all 50 →

Same molecule, other indications

Amitriptyline is also rated in:

Depressive Disorder, MajorDormant
BBB
Indicative ·
77 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
73 / 100
View asset →
EsketamineDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →